Prothya Biosolutions Netherlands - Crunchbase Company Profile & Funding

Overview

Prothya Biosolutions Netherlands

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Prothya Biosolutions Netherlands

CB Rank

394562

Biotech company providing solutions for blood protein based therapies

Acquired by

Prothya Biosolutions

Founded

obfuscation

Private

Amsterdam, Noord-Holland, The Netherlands

501-1000

www.prothya.com/

Biopharma

Biotechnology

Life Science

Pharmaceutical

Key People

Christopher Charles Lamb: Chief Executive Officer
Frank P. DeLucia: Chief Financial Officer

Details

Sub-Organization of

Prothya Biosolutions

Legal Name

Prothya Biosolutions Netherlands B.V.

Also Known As

Prothya Biosolutions

Operating Status

Active

Company Type

For Profit

Founders

Christopher Charles Lamb

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Immunoglobulin

A plasma-derived product containing antibodies used intravenously to support the immune system in treating immunodeficiency and neuromuscular disorders.

Albumin

A plasma-derived protein used in critical care to restore blood volume and treat conditions like severe burns, sepsis, or significant blood loss.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

M&A Details

Prothya Biosolutions Netherlands

merged with

Prothya Biosolutions

obfuscation

. This deal was done in

Stock

Transaction Name

Prothya Biosolutions Netherlands acquired by Prothya Biosolutions

Acquired by

Prothya Biosolutions

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

501-1000

Employee Profiles

Contacts

Employee Profiles

Christopher Charles Lamb Chief Executive Officer
Frank P. DeLucia Chief Financial Officer

News

Technology

View Tech Report

IT Spend

$8.2M

This year,

Prothya Biosolutions Netherlands

is projected to spend

$8.2M

on IT, according to Aberdeen.

Lists Featuring This Company

The Netherlands Companies With More Than 500 Employees

2,722 Number of Organizations • $146.9B Total Funding Amount • 450 Number of Investors

Pharmaceutical Companies With More Than 500 Employees

3,255 Number of Organizations • $435.6B Total Funding Amount • 2,293 Number of Investors

European Union (EU) Pharmaceutical Acquired Companies

511 Number of Organizations • $12.9B Total Funding Amount • 393 Number of Investors

The Netherlands Companies that Exited

3,234 Number of Organizations • $118.7B Total Funding Amount • 1,446 Number of Investors

Sub-Organizations

Number of Sub-Orgs

Which industries do these Sub-Organization operate in?

ProVen Pharmaceuticals

Division

Frequently Asked Questions

Where is

Prothya Biosolutions Netherlands

's headquarters?

Prothya Biosolutions Netherlands

is located in

Amsterdam, Noord-Holland, The Netherlands

Who are

Prothya Biosolutions Netherlands

's competitors? Alternatives and possible competitors to

Prothya Biosolutions Netherlands

may include

Takeda

Baxter International

, and

Grifols